The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index; 9 of the 38 sources its claims cite were checked for support.
Pre-, Pro-, Post- and Synbiotics in Pediatric Short Bowel Syndrome: A Narrative Review of Current Evidence
Open accessAbstract
BACKGROUND: Pediatric Short bowel syndrome (SBS) is the leading cause of intestinal failure and is characterized by persistent dysbiosis that negatively impacts intestinal adaptation and growth. Although microbiota modulation via pre-, pro-, and synbiotics represents a promising strategy, current evidence remains fragmented. This narrative review aims to critically assess the efficacy and safety of such interventions in the management of pediatric SBS. METHODS: A structured literature search was conducted on PubMed up to November 2025. Fourteen relevant studies were included, comprising clinical trials, preclinical animal models, and significant case reports regarding the use of biotics in SBS. RESULTS: The analysis reveals a microbiological dichotomy based on nutritional status: parenteral nutrition (PN)-dependent patients exhibit an excess of Proteobacteria associated with infectious risk, whereas weaned patients present a metabolic risk of D-lactic acidosis due to carbohydrate fermentation. Regarding efficacy, long-term synbiotic treatments (>12 months) demonstrated significant improvements in growth and nutritional status, likely mediated by increased production of short-chain fatty acids (SCFAs) and mucosal adaptation, unlike short-term probiotic cycles. However, serious adverse events (Lactobacillus sepsis and D-lactic acidosis) were reported, predominantly in patients with central venous catheters or malabsorption. CONCLUSIONS: Biotics offer therapeutic potential for intestinal failure, but their use cannot be empirical. The safety profile should be carefully selected, especially in central venous catheter (CVC) carriers. Future strategies must evolve towards precision medicine, prioritizing non-D-lactate-producing strains and personalized protocols based on the patient's nutritional phase.
Overview
CoChat Summary
TL;DR
This narrative review concludes that pre-, pro-, and synbiotics have theoretical and some observed benefits in pediatric short bowel syndrome, but clinical translation is constrained by very limited and heterogeneous evidence. Safety is a major concern: in about 50 pediatric patients across included studies and case reports, 4 serious adverse events (8%) were reported, mainly Lactobacillus bacteremia in catheter-dependent patients.
Key findings
- The review included 14 articles: 4 clinical studies, 4 preclinical/translational animal studies, and 6 case reports.
- In the cumulative analysis of approximately 50 pediatric patients, 4 serious adverse events (8%) were recorded; 3 of the 4 were Lactobacillus bacteremia, and the paper says these occurred in PN-dependent, CVC-carrying patients.
- Short-term probiotic trials were not clearly beneficial: a 4-week LGG study in 9 children with SBS found no significant improvement in intestinal permeability or stable colonization, and a 2-month trial in 18 weaned, suboptimally growing children found no significant differences in microbiota composition or anthropometric outcomes versus placebo.
- Long-term synbiotic therapy (>12 months) was associated with better outcomes: in one cohort of 7 children, 6/7 had accelerated weight gain and 5/7 improved rapid-turnover proteins; another small cohort showed increased fecal SCFAs and improved immunonutritional parameters.
Methods
- Narrative review with a structured PubMed search covering studies published from 2001 to November 2025; gray literature was excluded.
- Eligibility focused on pediatric postsurgical SBS (neonates, children, adolescents up to 18 years) and microbiota-targeted interventions; the initial search retrieved 32 articles, and 14 were included after screening.
- The review qualitatively synthesized clinical studies, animal studies, and case reports, with outcomes centered on safety (adverse events) and efficacy (symptom trends before/after treatment).
Limitations
- The paper states that evidence is scarce, heterogeneous, and largely non-randomized; it notes the lack of large-scale, multicenter randomized controlled trials limits statistical power and generalizability.
- The authors state that concurrent antibiotic use is a confounder that can independently alter dysbiosis or mask treatment effects.
- Evident from the text: the review’s included studies vary widely in design, strain, dose, duration, and delivery route, and the evidence base includes only small cohorts and case reports, which makes firm conclusions difficult.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
6 Valid · 0 Not valid · 23 Not checked · 25 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Reliance on PN and reduction in enteral feeding are other key contributors to intestinal flora alterations: as PN bypasses the intestine, fewer nutrients can reach the gut lumen, thus leading to a decreased microbial diversity and encouragement of pathogenic strains such as Enterobacteriaceae [9,10].”
§ Pre-, Pro-, Post- and Synbiotics in Pediatric Short Bowel Syndrome: A Narrative Review of Current Evidence > 1. Introduction > 1.2. Microbiota Alteration in Pediatric SBS
What the sources say
- Partly supportedcites [9] Zeichner, S.L., Mongodin, E.F., Hittle, L., Huang, S.H., and Torres, C. (2019). The bacterial communities of the small intestine and stool in children with short bowel syndrome. PLoS ONE, 14. sourceExperimental — accuracy not yet measured
The Discussion (page not provided) reports less diverse jejunal microbiota in children with short bowel syndrome receiving PN than in those receiving only enteral nutrition. The Results (page not provided) report higher abundance of some unclassified Enterobacteriaceae in jejunal samples from patients receiving PN. But the Discussion explicitly says it cannot determine whether PN decreased diversity; the paper does not establish the proposed nutrient-bypass mechanism or that PN encourages pathogenic strains. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [10] Boutte, 2022, Fecal microbiome and bile acid metabolome in adult short bowel syndrome, Am. J. Physiol. Gastrointest. Liver Physiol. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No study concerning the isolated use of prebiotics or postbiotics was identified during our search.”
§ Pre-, Pro-, Post- and Synbiotics in Pediatric Short Bowel Syndrome: A Narrative Review of Current Evidence > 3. Results > 3.2. Synbiotics
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The most frequently reported severe complication was Lactobacillus bacteremia, which accounted for three out of the four serious adverse events.”
§ Pre-, Pro-, Post- and Synbiotics in Pediatric Short Bowel Syndrome: A Narrative Review of Current Evidence > 4. Discussion
plainn = 50- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The second major safety signal is D-lactic acidosis, observed in one patient within the analyzed cohort.”
§ Pre-, Pro-, Post- and Synbiotics in Pediatric Short Bowel Syndrome: A Narrative Review of Current Evidence > 4. Discussion
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In our cumulative analysis of approximately 50 pediatric patients across the included studies and case reports, four serious adverse events (8%) were recorded, highlighting that these interventions are not devoid of risk.”
§ Pre-, Pro-, Post- and Synbiotics in Pediatric Short Bowel Syndrome: A Narrative Review of Current Evidence > 4. Discussion
plainn = 50- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
14 more claims
Create a free account to see all 54 claims and every source verdict.
- It may state two separate claims as one. 32
- Probably not a substantial claim. 3
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Pre-, Pro-, Post- and Synbiotics in Pediatric Short Bowel Syndrome: A Narrative Review of Current Evidence > Abstract
“This narrative review aims to critically assess the efficacy and safety of such interventions in the management of pediatric SBS.”
§ Pre-, Pro-, Post- and Synbiotics in Pediatric Short Bowel Syndrome: A Narrative Review of Current Evidence > 5. Conclusions
“In conclusion, the current body of evidence suggests that pre-, pro-, and symbiotic hold significant theoretical potential to mitigate dysbiosis and support intestinal adaptation in pediatric SBS.”
Citations
Cites
Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome
Kunz, A. N., Noel, J. M., & Fairchok, M. P. (2004) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200404000-00017 · Cited by 319 · cited 2×
“Similarly, Kunz et al. [29] described two cases of Lactobacillus bacteremia in children treated with LGG. Molecular analysis of the blood isolates and the administered probiotic product confirmed genetic identity, proving the probiotic was the source of infection.”
De Groote, M. A., Frank, D. N., Dowell, E., Glode, M. P., & Pace, N. R. (2005) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000154588.79356.e6 · Cited by 284
Enteric Microbial Flora, Bacterial Overgrowth, and Short-Bowel Syndrome
DiBaise, J. K., Young, R. J., & Vanderhoof, J. A. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.10.020 · Cited by 170 · cited 2×
“The altered motility and stasis occurring in shortened bowel, especially in cases of absence of the ileocecal valve, predispose to SIBO, which not only worsens dysbiosis but also contributes to further malabsorption [11,12].”
Overview of Pediatric Short Bowel Syndrome
Duro, D., Kamin, D., & Duggan, C. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181819007 · Cited by 147 · cited 1×
“SBS is the leading cause of pediatric intestinal failure, defined as the reduction in functional gut, leading to the inability of the remaining intestine to support normal growth and development, typically requiring parenteral nutrition (PN) [1].”
Intestinal dysbiosis in children with short bowel syndrome is associated with impaired outcome
Engstrand Lilja, H., Wefer, H., Nyström, N., Finkel, Y., & Engstrand, L. (2015) · Microbiome · doi:10.1186/s40168-015-0084-7 · Cited by 145 · cited 2×
“It is well established that the intestinal microbiota plays a fundamental role in the health of these patients; thus, recent research has been focusing on finding therapies to restore gut bacteria homeostasis [4].”
InfluentialKanamori, Y., Sugiyama, M., Hashizume, K., Yuki, N., Morotomi, M., & Tanaka, R. (2004) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2004.07.013 · Cited by 106 · cited 4×
“This biochemical shift was confirmed in the clinical setting [23], with evidence of doubling fecal SCFA concentrations, which correlated directly with accelerated weight gain and improved serum protein levels.”
InfluentialEizaguirre, I., Urkia, N. G., Asensio, A. B., Zubillaga, I., Zubillaga, P., Vidales, C., Garcia-Arenzana, J. M., & Aldazabal, P. (2002) · Journal of Pediatric Surgery · doi:10.1053/jpsu.2002.32256 · Cited by 88
Caporilli, C., Giannì, G., Grassi, F., & Esposito, S. (2023) · Nutrients · doi:10.3390/nu15102341 · Cited by 87 · cited 2×
“Postbiotic alternatives, such as heat-treated (non-viable) strains of Lactobacillus and Bifidobacterium, as well as purified SCFA formulations, might be more suitable for such fragile patients, as they do not colonize the gut or produce D-lactate, and might promote bifidogenic effects [3].”
Kanamori, Y., Hashizume, K., Sugiyama, M., Morotomi, M., & Yuki, N. (2001) · Digestive Diseases and Sciences · doi:10.1023/a:1010611920750 · Cited by 85 · cited 1×
“…( Bifidobacterium breve , Lactobacillus casei , galacto-oligosaccharides) rapidly restored a healthier anaerobic flora, reduced pathogenic overgrowth, and led to resolution of infections, metabolic instability, and feeding intolerance, ultimately enabling transition off parenteral nutrition [25].”
A case of D-lactic acid encephalopathy associated with use of probiotics
Munakata, S., Arakawa, C., Kohira, R., Fujita, Y., Fuchigami, T., & Mugishima, H. (2010) · Brain and Development · doi:10.1016/j.braindev.2009.09.024 · Cited by 78 · cited 3×
“Serum D-lactic acid levels were markedly elevated, and cessation of the probiotic, along with targeted antimicrobial therapy led to resolution of metabolic abnormalities and clinical symptoms [30].”
Cited by
Lactic acidosis in diabetic patients: diagnosis and treatment
Mankovsky, B., Halushko, O. A., & Gumeniuk, М. (2026) · Diabetes Obesity Metabolic Syndrome · doi:10.57105/2415-7252-2026-3-01
Awuchi, C. G., Atoki, A. V., & Echeta, C. K. (2026) · Cogent Food & Agriculture · doi:10.1080/23311932.2026.2738979 · Cited by 1
The role of gut microbiota in paediatric short bowel syndrome
Zeng, C., Liang, L., & Lv, T. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1970119
Metadata
- Authors
- Ruiz, R. G., Morelli, A., Grieco, R., Cardile, S., Capriati, T., Trovato, C. M., Bolasco, G., Knafelz, D., Bracci, F., Alterio, A., & Diamanti, A.
- Affiliations
- Università Cattolica del Sacro Cuore (IT)
- University of Salerno (IT)
- Bambino Gesù Children's Hospital (IT)
- Corresponding author
- Morelli, Annalisa
- ORCID
- Venue
- Children
- Publisher
- MDPI AG
- Published
- 2026-02-28
- Volume
- 13
- Issue
- 3
- Pages
- 349
- ISSN
- 2227-9067 (ISSN-L)
- PMC
- PMC13024854
- OpenAlex
- W7132827108
- Cited by
- 3
- References
- 34
- Citations by year
- 2026: 3
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Children (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Italian Ministry of Health with “Current Research funds”
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
- Keywords
- intestinal failure, prebiotics, probiotics, synbiotics, gut dysbiosis, gut microbiota, D-lactic acidosis, short-chain fatty acids, mucosal adaptation, parenteral nutrition, central venous catheters, precision medicine, nutritional status
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pre-, Pro-, Post- and Synbiotics in Pediatric Short Bowel Syndrome: A Narrative Review of Current Evidence. https://app.cochat.ai/papers/10.3390/children13030349
- The paper
- Ruiz, R. G., Morelli, A., Grieco, R., Cardile, S., Capriati, T., Trovato, C. M., Bolasco, G., Knafelz, D., Bracci, F., Alterio, A., & Diamanti, A. (2026). Pre-, Pro-, Post- and Synbiotics in Pediatric Short Bowel Syndrome: A Narrative Review of Current Evidence. Children. https://doi.org/10.3390/children13030349
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
